The present studies indicate that within lesional SSc microenvironments, tenascin-C functions as a ‘damage-associated molecular pattern' that is recognized as a TLR4 ligand and drives TLR4-dependent fibroblast activation underlying persistence of tissue fibrosis. The gene discussed is TLR4; the disease is systemic sclerosis.